<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ghormade, V.</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Pathan, E.K.</style></author></secondary-authors><tertiary-authors><author><style face="normal" font="default" size="100%">Deshpande, M.V</style></author></tertiary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Can fungi compete with marine sources for chitosan production?</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Biological Macromolecules</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cell wall</style></keyword><keyword><style  face="normal" font="default" size="100%">Chitin/chitosan</style></keyword><keyword><style  face="normal" font="default" size="100%">Waste Mycelial Biomass</style></keyword><keyword><style  face="normal" font="default" size="100%">Zygomycetous Fungi</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">NOV</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">104</style></volume><pages><style face="normal" font="default" size="100%">1415-1421</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Chitosan, a β-1,4-linked glucosamine polymer is formed by deacetylation of chitin. It has a wide range of applications from agriculture to human health care products. Chitosan is commercially produced from shellfish, shrimp waste, crab and lobster processing using strong alkalis at high temperatures for long time periods. The production of chitin and chitosan from fungal sources has gained increased attention in recent years due to potential advantages in terms of homogenous polymer length, high degree of deacetylation and solubility over the current marine source. Zygomycetous fungi such as Absidia coerulea, Benjaminiella poitrasii, Cunninghamella elegans, Gongrenella butleri, Mucor rouxii, Mucor racemosus and Rhizopus oryzae have been studied extensively. Isolation of chitosan are reported from few edible basidiomycetous fungi like Agaricus bisporus, Lentinula edodes and Pleurotus sajor-caju. Other organisms from mycotech industries explored for chitosan production are Aspergillus niger, Penicillium chrysogenum, Saccharomyces cerevisiae and other wine yeasts. Number of aspects such as value addition to the existing applications of fungi, utilization of waste from agriculture sector, and issues and challenges for the production of fungal chitosan to compete with existing sources, metabolic engineering and novel applications have been discussed to adjudge the potential of fungal sources for commercial chitosan production.&lt;/p&gt;</style></abstract><work-type><style face="normal" font="default" size="100%">Journal Article</style></work-type><custom3><style face="normal" font="default" size="100%">&lt;p&gt;Foreign&lt;/p&gt;</style></custom3><custom4><style face="normal" font="default" size="100%">3.138</style></custom4></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pathan, E.K.</style></author><author><style face="normal" font="default" size="100%">Tupe, S.G.</style></author><author><style face="normal" font="default" size="100%">Deshpande, M.V.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Fungal differentiation: a model phenomenon to screen antifungal drugs</style></title><secondary-title><style face="normal" font="default" size="100%">Developments in Fungal Biology and Applied Mycology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer</style></publisher><pub-location><style face="normal" font="default" size="100%">Singapore</style></pub-location><pages><style face="normal" font="default" size="100%"> 227-246</style></pages><isbn><style face="normal" font="default" size="100%">978-981-10-4767-1</style></isbn><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Pathogenic fungi change the morphology to a suitable vegetative form such as unicellular yeast or filamentous mycelium for the survival and proliferation in the host as well as to defeat cellular and physiological defences of the host. The microenvironment of the pathogen triggers different biochemical processes finally leading to differentiation. These biochemical processes, which correlate with morphological change from saprophytic/less virulent to pathogenic form, can be targeted for the development of novel antifungal agents. The present chapter deals with the role of differentiation in fungal pathogenesis and discusses different biochemical events as target for the antifungal strategies.</style></abstract><custom3><style face="normal" font="default" size="100%">Foreign</style></custom3><section><style face="normal" font="default" size="100%">Fungal differentiation: A model phenomenon to screen antifungal drugs</style></section></record></records></xml>